Insider Transactions in Q4 2023 at Lexeo Therapeutics, Inc. (LXEO)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 07
2023
|
Paul Mc Cormac Chief Technical Officer |
BUY
Conversion of derivative security
|
Direct |
3,191
+15.54%
|
-
|
|
Nov 07
2023
|
Omega Fund Vi, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
454,545
+17.4%
|
$4,999,995
$11.0 P/Share
|
|
Nov 07
2023
|
Omega Fund Vi, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,703,078
+32.22%
|
-
|
|
Nov 07
2023
|
Longitude Capital Partners Iv, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
454,545
+15.04%
|
$4,999,995
$11.0 P/Share
|
|
Nov 07
2023
|
Longitude Capital Partners Iv, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,112,555
+31.56%
|
-
|
|
Nov 07
2023
|
Invest A/S Lundbeckfond > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
227,272
+11.02%
|
$2,499,992
$11.0 P/Share
|
|
Nov 07
2023
|
Invest A/S Lundbeckfond > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,608,687
+32.57%
|
-
|